Stay updated with breaking news from Opal Computational Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
:max_bytes(150000):strip_icc()/GettyImages-1609713629-a18bedba0fc9458096ee57748e536c95.jpg)
Denmark’s Novo Nordisk struck a deal with U.S.-based health tech firm Valo Health to use AI to discover and develop treatments for cardiometabolic diseases such as heart attack, stroke, and diabetes.
Collaboration will apply Valo’s Opal Computational Platform™ and real-world patient dataset to enable the discovery and development of novel cardiometabolic drug programmes Novo Nordisk...
WILMINGTON, Mass. & DENVER--(BUSINESS WIRE)--Sep 14, 2023--
/PRNewswire/ -- Valo Health, Inc. ("Valo"), the technology company focused on transforming the drug discovery and development process using human-centric data...
/PRNewswire/ -- Valo Health, LLC ("Valo"), announced today the acquisition of TARA Biosystems, Inc. ("TARA"), a New York City-based cardiovascular disease...